Visits: 1755, Avg visit time (secs): 259,61 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 772 | 43,99% | |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 131 | 7,46% |
| /recipients.html | 58 | 3,30% |
| /medtronic/efsd-medtronic-recipients.html | 53 | 3,02% |
| /new_horizons/recipientsnh.html | 44 | 2,51% |
| /efsd-grant/efsd-clinres-recipients.html | 40 | 2,28% |
| /novo-t1/efsd-novo-t1-recipients.html | 40 | 2,28% |
| /msd/efsd-msd-recipients.html | 37 | 2,11% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 35 | 1,99% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 34 | 1,94% |
| /gsk/efsd-gsk-recipients.html | 31 | 1,77% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 791 | 45,07% |
| /efsd-grant/efsd-clinres-recipients.html | 149 | 8,49% |
| /novo-clinical-t2/efsd-novo-clin-t2-recipients.html | 108 | 6,15% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 60 | 3,42% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 44 | 2,51% |
| /novo-t1/efsd-novo-t1-recipients.html | 37 | 2,11% |
| /gsk/efsd-gsk-recipients.html | 36 | 2,05% |
| /lilly/efsd-lilly-recipients.html | 35 | 1,99% |
| /home.html | 24 | 1,37% |
| /servier/efsd-servier-recipients.html | 24 | 1,37% |
| /pfizer/efsd-pfizer-cardiorecipients.html | 22 | 1,25% |